Environment Minister Simonetta Sommaruga and Peruvian counterpart Kirla Echegaray Alfaro will sign the agreement on October 20 in a video conference. It still needs to be approved by Parliament. PRINCETON, N.J.—(BUSINESS WIRE) 24, 2015 — Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) today announced that Covance Drug Development (Covance) has received a multi-year award from a leading pharmaceutical company to use Covance`s Xcellerate® platform as a proprietary monitoring solution for its global portfolio of clinical trials. This pioneering agreement with a leading pharmaceutical company for Covance`s first software offering (SaaS) reflects the company`s unique technological capabilities and reinforces its position as an industry innovator and market leader in clinical IT solutions. “Switzerland is at the forefront internationally and sets a standard for international climate projects that meet high requirements for environmental protection while meeting international standards for the protection of human rights,” the government said on Wednesday. Let`s Make a Deal offers a dialogue between hotel staff and guests and offers specific measures to raise awareness of the impact of all our activities on the environment. In collaboration with We Are Water, Diamond Resorts will implement programs to inform people about their water use and encourage them to make simple changes, such as. B the reuse of bath towels and the limitation of water consumption, not in an intrusive way, but exciting for customers. The latter, well informed and involved in specific and concrete actions, become, on their return, the best communication agents and promoters of good practices. This press release contains forward-looking statements, including with respect to estimated guidance for 2015 and the impact of various factors on operating income. Each of the forward-looking statements is subject to change as a result of various important factors, including, but not limited to, market competition measures, adverse government and other third party actions, and the results of the Company`s acquisition of Covance.
Actual results may differ materially from those proposed in these forward-looking statements. For more information on potential factors that could affect LabCorp`s operating and financial results, see the Company`s Form 10-K for the year ended December 10, 2014 and the Company`s Form 10-Q for the quarter ended June 30, 2015, including under the heading Risk Factors, and in the company`s other SEC submissions, as well as the risk factors contained in Covance`s SEC submissions. The information contained in this press release should be read as part of a review of the Company`s submissions to the SEC, including the information contained in the Company`s Form 10-K for the year ended December 31, 2014 and the following Forms 10-Q under the heading GESTION`S DISCUSSION AND ANALYSE OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. Xcellerate® Monitoring redefines the new standard for risk-based surveillance on clinical trials Covance is revamping clinical trials to change the industry and improve lives. For more information about Xcellerate Monitoring and the full Xcellerate technology platform, see covance.com. By ratifying the Paris Agreement, Switzerland has committed to reducing greenhouse gas emissions by 50% by 2030 compared to 1990. This is to be achieved mainly through national measures, but the Paris Agreement also allows states to offset their own emissions through climate projects in other countries. They may take into account the emission reductions achieved in those countries as credits on their national reduction target.
. . .